Amifostine protects all of the following except:
## Core Concept
Amifostine is a cytoprotective agent used primarily to reduce the incidence of neutropenia-related fever and infection induced by chemotherapy and to decrease the cumulative toxicity of platinum-based chemotherapy on the kidneys. It works by protecting normal tissues from the damage caused by ionizing radiation and certain chemotherapeutic agents.
## Why the Correct Answer is Right
Amifostine exerts its protective effects through several mechanisms, including the scavenging of free radicals and the protection of DNA from damage. It is selectively taken up by normal tissues, where it activates various protective pathways. This results in the protection of normal tissues, such as the kidneys, bone marrow, and nerves, from the toxic effects of chemotherapy and radiation.
## Why Each Wrong Option is Incorrect
- **Option A:** Amifostine is known to protect the kidneys from the nephrotoxic effects of cisplatin, a chemotherapy agent. Therefore, this option is incorrect as it is indeed protected by amifostine.
- **Option B:** Amifostine helps protect the bone marrow, which can be affected by chemotherapy, leading to conditions like neutropenia. This protection reduces the risk of infections. Thus, this option is incorrect.
- **Option C:** The nerves can be protected from the neurotoxic effects of certain chemotherapeutic agents, making this option also incorrect.
## Why Option D is Correct
- **Option D:** The correct answer is related to the fact that amifostine does not significantly protect the tumor tissues from the effects of chemotherapy and radiation. This selectivity is the basis for its use in oncology—to allow for the continuation of cancer treatment while minimizing damage to normal tissues.
## Clinical Pearl / High-Yield Fact
A key point to remember is that amifostine's protective effects are most beneficial in the context of reducing nephrotoxicity from cisplatin and xerostomia from radiation therapy for head and neck cancer. Its use can help in maintaining the dose intensity of chemotherapy and allowing for the completion of planned treatments.
## Correct Answer: D. tumor tissue